R-EPOCH is a cancer treatment that combines six chemotherapy drugs ... The type of infusion method used (IV push, IV infusion, or continuous infusion) will vary depending on the location of ...

Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject ...

221 patients received endocrine therapy (everolimus plus exemestane or endocrine therapy alone), and 285 patients received chemotherapy (single-agent or combination intravenous chemotherapy or ...

Delhi State Cancer Institute (DSCI), an autonomous healthcare centre operating under Delhi govt's supervision, is facing a critical deficie.

Metastatic prostate cancer patients in the Capital Region now have a new treatment option at Ochsner MD Anderson Cancer ...

When Lucy Burch of Fort Ann found out the infusion center where she had been receiving treatment at for her rheumatoid ...

An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.

Biotech’s TROP2 antibody drug conjugate sac-TMT for marketing in second indication: Chengdu, China Wednesday, March 12, 2025, 11:00 Hrs [IST] Sichuan K ...

During a live event, Alexander I. Spira, MD, PhD, and participants discuss efficacy, adverse events, and sequencing of EGFR-mutated NSCLC treatments.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan ...